Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Comparative Study

Randomized Controlled Trial

Validation Study

Publication Year

From

Quick links

Individual year

2020

2018

2012

2010

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Physostigmine""[mesh_terms]

12 Results

Searching titles within these results

Development and optimization of a sublingual tablet formulation for physostigmine salicylate.

Noushin Bolourchian, Naghmeh Hadidi, Seyed Mohsen Foroutan, Bijan Shafaghi

Acta pharmaceutica (Zagreb, Croatia) 2010;59(3):301-12

Free Full Text

Abstract

Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling.

Georg Hempel, Gudrun Würthwein, Silke Gastine, Johannes B Zimmermann, Nadine Pinder, Thomas Bruckner, Stefanie Swoboda, Markus A Weigand, Torsten Hoppe-Tichy

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020;118():109318

Free Full Text

Abstract

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Muhammad S Nawaz, Mohammad A Kamal, Shazi Shakil, Qian-Sheng Yu, David Tweedie, Y Tan, Xianqin Qu, Nigel H Greig

CNS & neurological disorders drug targets 2018;16(7):820-827

Free Full Text

Abstract

Dementia.

James Warner, Pradeep Arya, Rob Butler

Clinical evidence 2005

Full Text

Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.

Melanie-Jayne R Howes, Nicolette S L Perry, Peter J Houghton

Phytotherapy research : PTR 2003;17(1):1-18

Full Text

Abstract

Dementia.

Balaji Wuntakal, James Warner, Rob Butler

Clinical evidence 2006

Full Text

Dementia.

James Warner, Rob Butler, Pramod Prabhakaran

Clinical evidence 2004

Full Text

Implication of novel biochemical property of beta-amyloid.

M Brzyska, A Bacia, D L Alkon, D Elbaum

Biochemical and biophysical research communications 2000;267(3):733-8

Full Text

Abstract

Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.

Carlos Medina, Shona Harmon, Iwona Inkielewicz, Maria Jose Santos-Martinez, Michael Jones, Paula Cantwell, Despina Bazou, Mark Ledwidge, Marek W Radomski, John F Gilmer

British journal of pharmacology 2012;166(3):938-49

Free Full Text

Abstract

Dementia.

Rob Butler, James Warner, Pradeep Arya

Clinical evidence 2005

Full Text

Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.

Corrado Blandizzi, Romano Danesi, Barbara De Paolis, Antonello Di Paolo, Rocchina Colucci, Alfredo Falcone, Mario Del Tacca

Clinical pharmacology and therapeutics 2002;71(4):263-71

Full Text

Abstract

Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).

Stefan Hofer, Markus A Weigand, Stefanie Swoboda, Torsten Hoppe-Tichy, Johannes B Zimmermann, Nadine Pinder, Thomas Bruckner, Monika Lehmann, Johann Motsch, Thorsten Brenner

Trials 2018;18(1):530

Free Full Text

Abstract

Results: 1 – 12 / 12

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Physostigmine""[mesh_terms]

Development and optimization of a sublingual tablet formulation for physostigmine salicylate.

Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling.

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Dementia.

Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders.

Dementia.

Dementia.

Implication of novel biochemical property of beta-amyloid.

Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.

Dementia.

Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role.

Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).

Results for
""Physostigmine""[mesh_terms]